Administration of fructose 1,6-diphosphate during early reperfusion significantly improves recovery of contractile function in the postischemic heart.

doi:10.1016/S0022-5223(98)70135-7

Paper

Administration of fructose 1,6-diphosphate during early reperfusion significantly improves recovery of contractile function in the postischemic heart.

Published Aug 1, 1998 · K. Takeuchi, H. Cao-Danh, I. Friehs

The Journal of thoracic and cardiovascular surgery

Q1 SJR score

41

Citations

2

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Animal Study

Study Snapshot

Fructose-1,6-diphosphate during early reperfusion significantly improves recovery of both diastolic and systolic function in postischemic hearts, with increased glucose uptake and higher phosphocreatine levels.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Administration of fructose 1,6-diphosphate during early reperfusion significantly improves recovery of contractile function in the postischemic heart.

References

Citations